Abstract:Berberine and jatrorrhizine are major bioactive components that are emerging as potential anti-cancer drugs. However, no zinc(II) – berberine/jatrorrhizine – curcumin compounds have been reported in the literature to date. Therefore, the molecular mechanisms associated with their cytotoxicity remain unexplored. To investigate the potential mitochondria-targeting ability, anti-neoplastic activity, and utility in cell imaging of berberine and jatrorrhizine derivates, four novel zinc(II) complexes, [Zn(Ber)(H2O)Cl2] (Zn(Ber)), [Zn(Ber)(Cur)Cl] (Zn(CurBer)), [Zn(Jat)(H2O)Cl2] (Zn(Jat)), and [Zn(Jat)(Cur)Cl] (Zn(CurJat)) bearing the berberine-derived ligand 2,2,2-trifluoroacetate 10-methoxy-9-((9-((2-(pyridin-2-yl)ethyl)amino)nonyl)oxy) −5,6-dihydro- [1,3]dioxolo[4,5-g]isoquinolino [(Torre et al., 2015; de Ruijter et al., 2020) 3,23,2-a]isoquinolin-7-ium (Ber), the jatrorrhizine-derived ligand 2,2,2-trifluoroacetate 2,9,10-trimethoxy-3-((9- ((2-(pyridin-2-yl)ethyl)amino)nonyl)oxy)-5,6-dihydroisoquinolino [(Torre et al., 2015; de Ruijter et al., 2020) 3,23,2-a]isoquinolin-7-ium (Jat), and/or curcumin (H-Cur) were first synthesised in this study. Zn(Ber), Zn(CurBer), Zn(Jat), and Zn(CurJat) showed higher cytotoxicity against human MCF-7 (breast adenocarcinoma) cells than did cisplatin, with IC50 values ranging from 0.21 to 4.45 μM. The anti-neoplastic activities of the zinc(II) – berberine/jatrorrhizine – curcumin complexes were in the following order: Zn(CurBer) > Zn(CurJat) > Zn(Ber) > Zn(Jat) > cisplatin > H-Cur > Ber > Jat > ZnCl2. Among these, Zn(CurBer) displayed the highest cytotoxicity (0.21 ± 0.06 μM). Furthermore, mechanistic investigations revealed that Zn(CurBer) and Zn(CurJat) could accumulate in the mitochondria, exhibit red fluorescence, and trigger mitophagy and apoptosis. In vivo anti-cancer evaluations also suggested that Zn(CurBer) inhibited MCF-7 xenograft tumour growth more effectively than cisplatin and Zn(CurJat). This is the first report describing the synthesis of zinc(II) – berberine/jatrorrhizine – curcumin complexes and their potential use as molecular probes and mitochondria-targeting anti-neoplastic drugs.

Complexes of Zn( ii ) with a mixed tryptanthrin derivative and curcumin chelating ligands as new promising anticancer agents

Zn(II)‐curcumin complexes‐based anticancer agents

Bifunctional tetrazole–carboxylate ligand based Zn(II) complexes: synthesis and their excellent potential anticancer properties

Two Copper(Ii) Complexes of Curcumin Derivatives: Synthesis, Crystal Structure and in Vitro Antitumor Activity

Manipulating Fe(II) spin states to achieve higher anti-tumor cell activities in multinuclear complexes

Cover Feature: Zn(II)‐Curcumin Complexes‐Based Anticancer Agents (ChemMedChem 23/2024)

Bifunctional Ruthenium(ii) Polypyridyl Complexes of Curcumin As Potential Anticancer Agents

The progresses in curcuminoids-based metal complexes: especially in cancer therapy.

Synthesis and in vitro anticancer activity of zinc(II) phthalocyanines conjugated with coumarin derivatives for dual photodynamic and chemotherapy.

An Asymmetric Binuclear Zinc(Ii) Complex With Mixed Iminodiacetate And Phenanthroline Ligands: Synthesis, Characterization, Structural Conversion And Anticancer Properties

Dithiocarbazate–Zn(II) complexes for photodynamic therapy and chemotherapy against lung cancer

Syntheses, Crystal Structures and Anticancer Activities of Three Novel Transition Metal Complexes with Schiff Base Derived from 2-Acetylpyridine and L-Tryptophan

A Curcumin-Based TPA Four-Branched Copper(ii) Complex Probe for in Vivo Early Tumor Detection.

Anticancer and biological properties of a Zn-2,6-diacetylpyridine bis(thiosemicarbazone) complex

Synthesis and crystal structure of a novel copper(II) complex of curcumin-type and its application in in vitro and in vivo imaging

Design, Synthesis, and biological evaluation of copper(II) complexes with phenanthroline-based ligands as potential anticancer agents

Triphenylamine and carbazole‐modified iridiumIII 2‐phenylpyridine complexes: Synthesis, anticaner application and targeted research

Polypyridyl CoII -Curcumin Complexes as Photoactivated Anticancer and Antibacterial Agents

Novel zinc(II)−curcumin molecular probes bearing berberine and jatrorrhizine derivatives as potential mitochondria-targeting anti-neoplastic drugs

Novel tetranuclear grid-like Zn(II) complexes derived from dihydrazone pyrimidine derivatives as antitumor agents

Synthesis, Characterization and Anticancer Activity of A Series of Curcuminoids and Their Half-Sandwich Ruthenium(Ii) Complexes